Next-generation probiotics for a healthier future

1stBiome is a gut-focused platform company engineering beneficial microbes to reduce low-grade inflammation and support metabolic health and longevity.

We combine advanced microbiology, genetic engineering, and deep biological insight to create scalable, affordable nutritional solutions with multiple downstream health benefits.

About Us

Get In Touch

Our platform

ONE TECHNOLOGY,
MULTIPLE HEALTH BENEFITS

The 1stBiome platform is designed to address key biological drivers of chronic disease and aging through targeted modulation of the gut:

Reduction of endotoxins and oxidative stress in the colon
Shaping the microbiome toward a healthier, more resilient composition
Improved appetite control and metabolic signaling
Support for longevity by reducing inflammation-driven biological stress over time

This platform enables the development of multiple gut-targeted products built on a shared scientific foundation.

01.

PROBLEM

Low-Grade Inflammation:
A Hidden Driver of Chronic Disease

Our first product focuses on low-grade inflammation, a foundational biological process underlying many chronic conditions.

Low-grade inflammation is a silent but powerful driver of diseases such as colon cancer, diabetes, arthritis, and obesity. Unlike acute inflammation, it develops gradually and often goes unnoticed until disease is established. Current interventions are largely reactive, costly, or focused on symptom management rather than prevention.

At the same time, healthcare systems face increasing pressure from aging populations, obesity, and metabolic disease, alongside limited access to affordable, science-based nutritional solutions that support long-term gut and metabolic health.

Gut-Targeted Solutions for Systemic Health

1stBiome addresses low-grade inflammation at its source with gut-focused, microbial solutions designed for early and preventive intervention.

We develop affordable, oral nutritional products that promote metabolic health, healthy aging, and weight management.

Our solutions are brought to market through partnerships with established consumer health and nutrition brands and are supported by strong scientific evidence.

02.

SOLUTION

The problem:

Silent inflammation

Low-grade colon inflammation develops silently over time
Drives diseases such as colon cancer, diabetes, arthritis, and obesity
Current solutions are reactive and costly

Chronic Disease

Our solution:

Prevention at the source

Targets low-grade colon inflammation before disease progression
Gut-focused, science-based approach
Affordable, oral solutions designed for scale

Healthy outcomes

Want to build a healthier future?

We seek collaboration with established brands in the dietary health business and together bring next generation of super performing probiotics to the market.